Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experiment

Diabet. Med. 29, 869–877 (2012)

[1]  Kathryn A Phillips,et al.  Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. , 2002, Health services research.

[2]  Jordan J. Louviere,et al.  Using stated preference discrete choice modeling to evaluate health care programs , 2004 .

[3]  J. Habbema,et al.  Preferences for colorectal cancer screening strategies: a discrete choice experiment , 2010, British Journal of Cancer.

[4]  Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis , 2012, BMJ : British Medical Journal.

[5]  E W Steyerberg,et al.  What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment. , 2010, European journal of cancer.

[6]  A Ludbrook,et al.  Use of discrete choice experiments to elicit preferences , 2001, Quality in health care : QHC.

[7]  A. Sheikh,et al.  Email consultations in health care: 1—scope and effectiveness , 2004, BMJ : British Medical Journal.

[8]  F. Johnson,et al.  Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agents , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[9]  M. Lai,et al.  Using discrete choice experiment to elicit doctors' preferences for the report card design of diabetes care in Taiwan - a pilot study. , 2010, Journal of evaluation in clinical practice.

[10]  E. Agardh,et al.  Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy , 2011, Diabetes Care.

[11]  Screening for diabetic retinopathy. , 2003, Journal of the Royal Society of Medicine.

[12]  R. Edwards,et al.  Diabetic retinopathy screening: a systematic review of the economic evidence , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[13]  M. Wallander,et al.  Trends in the prevalence and incidence of diabetes in the UK: 1996–2005 , 2009, Journal of Epidemiology & Community Health.

[14]  M. Bachmann,et al.  Trends in yield and effects of screening intervals during 17 years of a large UK community‐based diabetic retinopathy screening programme , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[15]  Mandy Ryan,et al.  Using discrete choice experiments to value health care programmes: current practice and future research reflections. , 2003, Applied health economics and health policy.

[16]  Simon P Harding,et al.  Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study , 2003, The Lancet.

[17]  E. Stefánsson,et al.  Biennial eye screening in patients with diabetes without retinopathy: 10-year experience , 2007, British Journal of Ophthalmology.

[18]  Paul Kind,et al.  UK population norms for EQ-5D , 1999 .

[19]  M Ryan,et al.  Eliciting public preferences for healthcare: a systematic review of techniques. , 2001, Health technology assessment.

[20]  S. Harding,et al.  Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[21]  Kathryn A Phillips,et al.  How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. , 2009, Health economics.

[22]  L. Lynd,et al.  Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes. , 2009, Diabetes technology & therapeutics.

[23]  G. Launoy,et al.  Eliciting Population Preferences for Mass Colorectal Cancer Screening Organization , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[24]  Mandy Ryan,et al.  Use of discrete choice experiments to elicit preferences , 2001 .

[25]  L. Matza,et al.  Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes , 2006, Health and quality of life outcomes.

[26]  C. Bunce,et al.  Causes of blind certifications in England and Wales: April 1999–March 2000 , 2008, Eye.

[27]  L. Lynd,et al.  A valuation of patients' willingness-to-pay for insulin delivery in diabetes , 2009, International Journal of Technology Assessment in Health Care.

[28]  Stanley Mirsky,et al.  Screening for diabetic retinopathy , 2003, The Lancet.